These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 2734726)

  • 1. [In vitro demonstration of hydroxylation of pentoxifylline].
    Poirier JM; Lebot M; Cheymol G
    Therapie; 1989; 44(1):69-70. PubMed ID: 2734726
    [No Abstract]   [Full Text] [Related]  

  • 2. Pentoxifylline for intermittent claudication.
    Med Lett Drugs Ther; 1984 Nov; 26(675):103-4. PubMed ID: 6390108
    [No Abstract]   [Full Text] [Related]  

  • 3. [Concentration of orally administered pentoxyfyllin in seminal fluid].
    Schramm P; Hinze HJ
    Andrologia; 1980; 12(5):482-4. PubMed ID: 7447061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The excretion of pentoxifylline and its metabolites into human breast milk.
    Witter FR; Smith RV
    Am J Obstet Gynecol; 1985 Apr; 151(8):1094-7. PubMed ID: 3985069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absorption, distribution, excretion, and metabolism of 1-(5-oxohexyl) theobromine (BL 191) in rats.
    Fujimoto K; Yoshida S; Moriyama Y; Sakaguchi T
    Chem Pharm Bull (Tokyo); 1976 Jun; 24(6):1137-45. PubMed ID: 1021279
    [No Abstract]   [Full Text] [Related]  

  • 6. Release of plasminogen activator by pentoxifylline and its major metabolite.
    Klöcking HP; Hoffmann A; Markwardt F
    Thromb Res; 1987 Jun; 46(5):747-50. PubMed ID: 3629547
    [No Abstract]   [Full Text] [Related]  

  • 7. Simultaneous determination of pentoxifylline and its hydroxy metabolite in plasma by high-performance liquid chromatography.
    Chivers DA; Birkett DJ; Miners JO
    J Chromatogr; 1981 Sep; 225(1):261-5. PubMed ID: 7298755
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug therapy for peripheral arterial disease.
    Naide D
    Am Fam Physician; 1986 Sep; 34(3):215-7. PubMed ID: 3751848
    [No Abstract]   [Full Text] [Related]  

  • 9. Determination of pentoxifylline and a major metabolite, 3,7-dimethyl-1-(5'-hydroxyhexyl)xanthine, by high-performance liquid chromatography.
    Luke DR; Rocci ML
    J Chromatogr; 1986 Jan; 374(1):191-5. PubMed ID: 3949928
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of pentoxifylline clearance by cimetidine.
    Luke DR; Rocci ML; Hoholick C
    J Pharm Sci; 1986 Feb; 75(2):155-7. PubMed ID: 3958924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism and pharmacokinetics of 14C-pentoxifylline in healthy volunteers.
    Bryce TA; Chamberlain J; Hillbeck D; Macdonald CM
    Arzneimittelforschung; 1989 Apr; 39(4):512-7. PubMed ID: 2751739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of pentoxifylline and its 5-hydroxy metabolite in human plasma by solid-phase extraction and high-performance liquid chromatography with ultraviolet detection.
    Musch G; Hamoir T; Massart DL
    J Chromatogr; 1989 Oct; 495():215-26. PubMed ID: 2613806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of 1-(3'-carboxypropyl)-3,7-dimethylxanthine and 1-(4'-carboxybutyl)-3,7-dimethylxanthine, two major metabolites of oxpentifylline, in urine by high-performance liquid chromatography.
    Bryce TA; Burrows JL; Jolley KW
    J Chromatogr; 1985 Nov; 344():397-402. PubMed ID: 4086565
    [No Abstract]   [Full Text] [Related]  

  • 14. Microbial models of mammalian metabolism: stereospecificity of ketone reduction with pentoxifylline.
    Davis PJ; Yang SK; Smith RV
    Xenobiotica; 1985 Dec; 15(12):1001-10. PubMed ID: 3911603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gas chromatographic determination of pentoxifylline and its major metabolites in human breast milk.
    Bauza MT; Smith RV; Knutson DE; Witter FR
    J Chromatogr; 1984 Sep; 310(1):61-9. PubMed ID: 6501523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbial models of mammalian metabolism: microbial reduction and oxidation of pentoxifylline.
    Davis PJ; Yang SK; Smith RV
    Appl Environ Microbiol; 1984 Aug; 48(2):327-31. PubMed ID: 6486781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pentoxifylline in end-stage renal disease.
    Silver MR; Kroboth PD
    Drug Intell Clin Pharm; 1987 Dec; 21(12):976-8. PubMed ID: 3428162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of pentoxifylline on platelet aggregation.
    Nenci GG; Gresele P; Agnelli G; Ballatori E
    Pharmatherapeutica; 1981; 2(8):532-8. PubMed ID: 7255510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microbial transformation of hydroxy metabolites of 1-oxohexyl derivatives of theobromine by Cunninghamella echinulata NRRL 1384.
    Pekala E; Kochan M; Carnell AJ
    Lett Appl Microbiol; 2009 Jan; 48(1):19-24. PubMed ID: 19018970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The release of prostacyclin (PGI2) by pentoxifylline from human vascular tissue.
    Matzky R; Darius H; Schrör K
    Arzneimittelforschung; 1982; 32(10):1315-8. PubMed ID: 6817760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.